scispace - formally typeset
P

Pornsak Sriamornsak

Researcher at Silpakorn University

Publications -  191
Citations -  7683

Pornsak Sriamornsak is an academic researcher from Silpakorn University. The author has contributed to research in topics: Dissolution testing & Drug delivery. The author has an hindex of 41, co-authored 177 publications receiving 6574 citations. Previous affiliations of Pornsak Sriamornsak include University of Sydney & Royal Society.

Papers
More filters
Journal ArticleDOI

Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems

TL;DR: The frontline drug doxorubicin has been used for treating cancer for over 30 years but causes toxicity to most major organs, especially life‐threatening cardiotoxicity, which forces the treatment to become dose‐limiting.
Journal ArticleDOI

Mucoadhesive properties of various pectins on gastrointestinal mucosa: An in vitro evaluation using texture analyzer

TL;DR: Pectin can be used as a mucoadhesive carrier for GI-mucoad adhesive drug delivery systems, and higher degree of esterification and molecular weight gave a stronger muco adhesion.

Research paper Mucoadhesive properties of various pectins on gastrointestinal mucosa: An in vitro evaluation using texture analyzer

TL;DR: In this article, the performance of various pectins with different degrees of esterification and molecular weights was examined with porcine gastrointestinal (GI) mucosa, i.e. buccal, stomach, small intestine and large intestine, using a texture analyzer equipped with a mucoadhesive platform.
Journal ArticleDOI

Swelling, erosion and release behavior of alginate-based matrix tablets.

TL;DR: The extent of matrix swelling, erosion, and diffusion of drug determined the kinetics as well as mechanism of drug release from alginate-based matrix tablets.
Journal ArticleDOI

Application of pectin in oral drug delivery

TL;DR: Pectin-based controlled release systems, gastro-retentive systems and mucoadhesive systems present promising approaches for increasing the bioavailability of drugs, but are in their infancy.